11/07/2013 18:45:00

U.K. Recalls Drugs Made in India

LONDON--In another sign of possible manufacturing problems in India's pharmaceutical industry, the U.K.'s medicines regulator said it was recalling 16 drugs made by Wockhardt Ltd. (532300.BY) after finding "manufacturing deficiencies" at one of the company's factories in India.

The Medicines and Healthcare products Regulatory Agency, or MHRA, called it a "precautionary recall," as there is no evidence that the medicines are defective. The agency said it is recalling the drugs from pharmacies and wholesalers but isn't asking patients to return their Wockhardt medicines.

"There is no evidence of a patient safety risk. ...however, the MHRA has to act in the interest of public health as poor manufacturing standards cannot be allowed to continue," the agency said.

The recalled drugs, manufactured in the central Indian city of Waluj, include treatments for infections, hypertension, diabetes, epilepsy and other diseases. The MHRA said the plant suffered from "poor cleaning practices" and defective ventilation systems. The agency inspection also found evidence of "forged documents relating to staff training records."

In an emailed statement, Wockhardt confirmed the news and said the recall would result in a one-time charge of 1.5 million pounds ($2.25 million) this year. Exports from the Waluj plant constitute less than 5% of the company's total U.K. sales and less than 2% of overall sales, it added.

It was the second recent setback for the company and its Waluj factory. In May, the U.S. Food and Drug Administration imposed an import ban on products from the factory after it failed an FDA safety inspection. The FDA didn't elaborate on the problems it found.

In a conference call at the time, Wockhardt Chairman Habil Khorakiwala said the company was implementing "corrective measures to be in compliance with the FDA guidelines." He said the U.S. import ban could cost the company $100 million in revenue this fiscal year. Wockhardt generated total revenue of 25.6 billion rupees ($460.6 million) in the year ended March 31, 2012.

Also in May, India's Ranbaxy Laboratories Ltd. (500359.BY) agreed to pay $500 million in civil and criminal fines for exporting adulterated drugs to the U.S.

In a phone interview Thursday, D.G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry body, said the group has written to the FDA asking it to conduct workshops with Indian companies to correct erroneous practices.

"Companies need to better understand FDA processes, and there needs to be a correction in their organizational culture, right from drug discovery to development and production," Mr. Shah said.

Write to Jeanne Whalen at jeanne.whalen@wsj.com and Anirban Chowdhury at anirban.chowdhury@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 11, 2013 13:45 ET (17:45 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
03 Jul
OMXC20
  Der har på det seneste været noget debat om DCF-analyser og andre måder at forsøge at finde en fai..
31
01 Jul
OMXC20
Der har været en del kritik og undren over mine indlæg - især om Jobindex. Her er forklaringen på, h..
20
02 Jul
CBRAIN
Til alle de, der er blevet støt over at jeg ændrede syn på cBrain for et lille års tid siden er her ..
16
01 Jul
OMXC20
Nej, børns loyalitet over for deres forældre svigter aldrig. Men hvis du har tjent lidt penge, så an..
13
30 Jun
EXQ
Exiqon har idag lanceret deres Cloud Platform XploreRNA som kan ses via følgende link:   https://xpl..
13
03 Jul
 
Dette er ikke en hype af nedenstående selskaber, men en tak til en mand, der for mig at se har en go..
12
28 Jun
I:DAX
Ja hele Boriz show med Bear og Bull x18 er helt vanvittigt, men jeg orker ikke at kommentere mere på..
12
30 Jun
SAS-DKK
Ryanair bedriver landsskadelig virksomhed i Danmark. De bør smides ud.                       Desværr..
11
04 Jul
JOBNDX
Endnu et langt indlæg og endnu en ny tråd. Men alligevel ingen svar på det væsentlige. Skal vi så ge..
10
03 Jul
 
Hvem har fortalt dig, at randzoner og udsultning af jorden hjælper miljøet. De virkemidler der er ta..
10

Form 8.3 - AXA INVESTMENT MANAGERS S.A.: Royal Dutch Shell Plc

03/07/2015 15:44:41
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE ..

Alliance Trust PLC : Net Asset Value(s)

03/07/2015 13:59:19
ALLIANCE TRUST PLC At the close of business on Thursday 02 July 2015, the unaudited net asset value per ordinary share of 2.5p, valued on a bid price b..

Form 8.5 (EPT/RI) - 888 Holdings plc

03/07/2015 09:43:26
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY..

Most read news

  • 24 hours
  • 48 hours
  • 1 week

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2015   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
05 July 2015 10:28:11
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20150702.1 - EUROWEB6 - 2015-07-05 11:28:11 - 2015-07-05 10:28:11 - 1000 - Website: OKAY